$2.04 (2.26%)

Volume: 6.651k

Closed: Mar 28, 2023

Hollow Logo Score: -3.305
Cellectis S.A. Stock
$2.04 (2.26%)

Volume: 6.651k

Closed: Mar 28, 2023

Score Hollow Logo -3.305

Cellectis S.A. Stock Insider Trading

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis SA Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE